Filing Details

Accession Number:
0001209191-23-050293
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-21 16:56:48
Reporting Period:
2023-09-19
Accepted Time:
2023-09-21 16:56:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1445283 Kineta Inc. KA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730052 J. Raymond Bartoszek C/O Kineta, Inc.
219 Terry Ave. N., Suite 300
Seattle WA 98109
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-19 2,000 $2.37 14,956 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 844,478 Indirect By RLB Holdings Connecticut LLC
Common Stock 1,001 Indirect By son
Common Stock 1,000 Indirect By daughter
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.33 to $2.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The Reporting Person is a managing member of RLB Holdings, LLC ("RLB Holdings") and RLB Holdings Connecticut LLC ("RLB Connecticut") and shares voting and dispositive power over the shares held by RLB Holdings and RLB Connecticut. As such, the Reporting Person may be deemed to beneficially own such shares held by RLB Holdings and RLB Connecticut.